Cite
Reuss JE, Brigham E, Psoter KJ, et al. Pretreatment Lung Function and Checkpoint Inhibitor Pneumonitis in NSCLC. JTO Clin Res Rep. 2021;2(10):100220doi: 10.1016/j.jtocrr.2021.100220.
Reuss, J. E., Brigham, E., Psoter, K. J., Voong, K. R., Shankar, B., Ettinger, D. S., Marrone, K. A., Hann, C. L., Levy, B., Feliciano, J. L., Brahmer, J. R., Feller-Kopman, D., Lerner, A. D., Lee, H., Yarmus, L., Hales, R. K., D'Alessio, F., Danoff, S. K., Forde, P. M., Suresh, K., & Naidoo, J. (2021). Pretreatment Lung Function and Checkpoint Inhibitor Pneumonitis in NSCLC. JTO clinical and research reports, 2(10), 100220. https://doi.org/10.1016/j.jtocrr.2021.100220
Reuss, Joshua E, et al. "Pretreatment Lung Function and Checkpoint Inhibitor Pneumonitis in NSCLC." JTO clinical and research reports vol. 2,10 (2021): 100220. doi: https://doi.org/10.1016/j.jtocrr.2021.100220
Reuss JE, Brigham E, Psoter KJ, Voong KR, Shankar B, Ettinger DS, Marrone KA, Hann CL, Levy B, Feliciano JL, Brahmer JR, Feller-Kopman D, Lerner AD, Lee H, Yarmus L, Hales RK, D'Alessio F, Danoff SK, Forde PM, Suresh K, Naidoo J. Pretreatment Lung Function and Checkpoint Inhibitor Pneumonitis in NSCLC. JTO Clin Res Rep. 2021 Aug 26;2(10):100220. doi: 10.1016/j.jtocrr.2021.100220. eCollection 2021 Oct. PMID: 34746881; PMCID: PMC8552105.
Copy
Download .nbib